Recombinant <i>Mycobacterium bovis</i> BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy

During 2022, AIDS claimed a life every minute and about 9.2 million HIV-infected people were not on treatment. In addition, a person living with HIV is estimated to be 20–30 times more susceptible to developing active tuberculosis. Every year, 130,000 infants are newly infected, with vertical transm...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Joan Joseph-Munné, Milena Maya-Hoyos, Narcís Saubi, Santiago Perez, Miguel Angel Martinez Lopez, Eder Baron, Carlos Yesid Soto
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-06-01
Schriftenreihe:	Vaccines
Schlagworte:	HIV rBCG BCG AIDS live-attenuated vaccines mycobacteria
Online-Zugang:	https://www.mdpi.com/2076-393X/13/6/606
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!